These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 16926626

  • 1. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J, Sterz J, Krebbel H, Zavrski I, Kaiser M, Zang C, Heider U, Jakob C, Elstner E, Sezer O.
    Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
    [Abstract] [Full Text] [Related]

  • 2. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C, Liu H, Posch MG, Waechter M, Facklam M, Fenner MH, Ruthardt M, Possinger K, Phillip Koeffler H, Elstner E.
    Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
    [Abstract] [Full Text] [Related]

  • 4. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T, Fujiwara Y, Hamaguchi M, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Higuchi K, Arakawa T.
    Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ, Park KS, Chung SY, Sheen YY, Moon DC, Song YS, Kim KS, Song S, Yun YP, Lee MK, Oh KW, Yoon DY, Hong JT.
    J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D, Yoshihiro H, Nakanishi M, Naruyama H, Okada S, Ando R, Tozawa K, Kohri K.
    Cancer Detect Prev; 2008 Nov; 32(3):259-66. PubMed ID: 18789607
    [Abstract] [Full Text] [Related]

  • 7. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J, Xia Q, Zhang Q, Li H, Zhang J, Li A, Xiu R.
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 10. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE, Gould H, Harris T, Bonacci JV, Stewart AG.
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [Abstract] [Full Text] [Related]

  • 11. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J, Kim BH, Kim YI, Kim KY, Hwangbo Y, Jang JY, Dong SH, Kim HJ, Chang YW, Chang R.
    Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
    [Abstract] [Full Text] [Related]

  • 12. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY, Tseng CC.
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y, Huang RW.
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [Abstract] [Full Text] [Related]

  • 14. Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma.
    Eucker J, Bängeroth K, Zavrski I, Krebbel H, Zang C, Heider U, Jakob C, Elstner E, Possinger K, Sezer O.
    Anticancer Drugs; 2004 Nov; 15(10):955-60. PubMed ID: 15514564
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
    Burton JD, Castillo ME, Goldenberg DM, Blumenthal RD.
    Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
    [Abstract] [Full Text] [Related]

  • 16. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P, Thalhammer T, Jäger W, Aust S, Steiner G, Ensinger C, Obrist P.
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
    Liu J, Lu H, Huang R, Lin D, Wu X, Lin Q, Wu X, Zheng J, Pan X, Peng J, Song Y, Zhang M, Hou M, Chen F.
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):400-8. PubMed ID: 15838654
    [Abstract] [Full Text] [Related]

  • 18. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
    Yuan J, Takahashi A, Masumori N, Uchida K, Hisasue S, Kitamura H, Itoh N, Tsukamoto T.
    Urology; 2005 Mar; 65(3):594-9. PubMed ID: 15780399
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
    Laurora S, Pizzimenti S, Briatore F, Fraioli A, Maggio M, Reffo P, Ferretti C, Dianzani MU, Barrera G.
    J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
    [Abstract] [Full Text] [Related]

  • 20. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM, Wright KL, Whittaker P, Chakravarty P, Watson ML, Ward SG.
    Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.